(Q37037053)

17 August 2017

1 reference

title

Genetics of Parkinson disease. (English)

1 reference

17 August 2017

1 reference

2

Tatiana Foroud

0 references

Nathan Pankratz

series ordinal

1

object named as

Nathan Pankratz

0 references

language of work or name

English

0 references

publication date

1 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

9

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

801-811

1 reference

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

An estimate of the incidence of depression in idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The occurrence of depression in Parkinson's disease. A community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Smoking and Parkinson's disease: systematic review of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Temporal relationship between cigarette smoking and risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Pooled analysis of tobacco use and risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Association of coffee and caffeine intake with the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Caffeine, postmenopausal estrogen, and risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Prior history of head trauma in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Head trauma preceding PD: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Pesticides and risk of Parkinson disease: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Pesticide exposure and risk for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Follow-up study of early-life protective and risk factors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Occupational and environmental risk factors for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Animal models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Familial aggregation of Parkinson's disease in a Finnish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Familial Aggregation of Parkinson's Disease in Iceland

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Parkinson's disease and environmental factors. Matched case-control study in the Limousin region, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Familial aggregation of Parkinson's disease: A population-based case-control study in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Genetic factors in the etiology of idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Pathoanatomy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Low frequency of alpha-synuclein mutations in familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Analysis of the coding and the 5' flanking regions of the alpha-synuclein gene in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Alpha-synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Failure to find alpha-synuclein gene dosage changes in 190 patients with familial Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

G2019S LRRK2 mutation in French and North African families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Lrrk2 and Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Parkinsonism, Lrrk2 G2019S, and tau neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

LRRK2 in Parkinson's disease: protein domains and functional insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

LRRK2 gene in Parkinson disease: Mutation analysis and case control association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Kinase activity of mutant LRRK2 mediates neuronal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Heterozygous mutation in 5'-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The ubiquitin pathway in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Genetic causes of Parkinson's disease: UCHL-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

UCHL-1 is not a Parkinson's disease susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

How much phenotypic variation can be attributed to parkin genotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Lewy bodies and parkinsonism in families with parkin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Distribution, type, and origin of Parkin mutations: review and case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Gro

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Association between early-onset Parkinson's disease and mutations in the parkin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Complex relationship between Parkin mutations and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Novel PINK1 mutations in early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

PINK1 (PARK6) associated Parkinson disease in Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

PINK1 mutation heterozygosity and the risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The role of pathogenic DJ-1 mutations in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

DJ-1 has a role in antioxidative stress to prevent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Genome-wide scan for Parkinson's disease: the GenePD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Age at onset in two common neurodegenerative diseases is genetically controlled

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Genes influencing Parkinson disease onset: replication of PARK3 and identification of novel loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

High-resolution whole-genome association study of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Genomewide association, Parkinson disease, and PARK10

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Considerations for genomewide association studies in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Variability and validity of polymorphism association studies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Dopamine neuron agenesis in Nurr1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mutations in NR4A2 associated with familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

No pathogenic mutations in the synphilin-1 gene in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Motor signs during the course of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Apolipoprotein E controls the risk and age at onset of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Phenotypic associations of tau and ApoE in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Apolipoprotein E and dementia in Parkinson disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Age at onset of Parkinson disease and apolipoprotein E genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Analysis of the glucocerebrosidase gene in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Glucocerebrosidase mutations in subjects with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The role of tau (MAPT) in frontotemporal dementia and related tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Tau gene and Parkinson's disease: a case-control study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The Tau Gene Haplotype H1 Confers a Susceptibility to Parkinson’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Origin and functional consequences of the complex I defect in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Point mutations of mitochondrial genome in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Mutations in LRRK2 other than G2019S are rare in a north american–based sample of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

The parkin gene and its phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Heterozygousparkinpoint mutations are as common in control subjects as in Parkinson's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Chromosome 5 and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Absence of previously reported variants in theSCNA (G88C and G209A),NR4A2 (T291D and T245G) and theDJ-1 (T497C) genes in familial Parkinson's disease from theGenePD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Genetic Analysis of Synphilin-1 in Familial Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

APOE and the risk of PD with or without dementia in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Lrrk2 pathogenic substitutions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Lack of mutations in DJ-1 in a cohort of Taiwanese ethnic Chinese with early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Case-control study of the ?-synuclein interacting protein gene and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

Apolipoprotein E ɛ4 allele is associated with Parkinson disease risk in a Mexican Mestizo population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

A heterozygous effect for PINK1 mutations in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31815BF97C

10.1097/GIM.0B013E31815BF97C

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

1007487055

0 references

1 reference